Skip Nav Destination
Latest in Immuno-oncology
May 23 2022
The Tumor Immune Profile of Murine Ovarian Cancer Models: An Essential Tool For Ovarian Cancer Immunotherapy Research.
Galaxia M Rodriguez, Kristianne J.C. Galpin et al.
May 09 2022
Neoantigen Presentation and IFNγ Signaling on the Same Tumor-associated Macrophage are Necessary for CD4 T Cell–mediated Antitumor Activity in Mice
Ainhoa Perez-Diez, Xiangdong Liu et al.
May 09 2022
Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas
Anne W.J. Martens, Joanne M. Rietveld et al.
May 05 2022
Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell Lymphoma
Paul A. Hamlin, Vasile Musteata et al.
March 23 2022
March 22 2022
Conduit CAR: Redirecting CAR T-Cell Specificity with A Universal and Adaptable Bispecific Antibody Platform
M. Jack Borrok, Yonghai Li et al.
February 10 2022
Resolving the Heterogeneous Tumor-Centric Cellular Neighborhood through Multiplexed, Spatial Paracrine Interactions in the Setting of Immune Checkpoint Blockade
Rachel L.G. Maus, Alexey A. Leontovich et al.
January 28 2022
Chimeric Antigen Receptors Directed at Mutant KRAS Exhibit an Inverse Relationship Between Functional Potency and Neoantigen Selectivity
Talar Tokatlian, Grace E. Asuelime et al.
January 20 2022
December 02 2021
Combinatorial Natural Killer Cell–based Immunotherapy Approaches Selectively Target Chordoma Cancer Stem Cells
Austin T.K. Hoke, Michelle R. Padget et al.